FDA announces Class I recall of Cardiosave intra-aortic balloon pumps (IABPs)
The FDA, on December 16, identified the recall by Getinge/Datascope/Maquet of its Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious.
The FDA, on December 16, identified the recall by Getinge/Datascope/Maquet of its Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious.
Getinge/Datascope/Maquet is recalling these products due to complaints of fluid leaks. Fluid entering the Cardiosave IABP may cause unexpected pump shutdown or the inability to initiate therapy.
There has been one death and 71 complaints reported about this device issue.
Datascope/Getinge/Maquet plan to have representatives correct these issues by installing internal and external upgrades on every device.
The recall is the second related to the intra-aortic balloon pumps since Nov. 1, when the company issued a recall of 137 battery packs.
Read more:
https://www.fda.gov/
Forum Categories
Monthly archive
- August 2021 (4)
- September 2021 (12)
- October 2021 (11)
- November 2021 (11)
- December 2021 (11)
- January 2022 (8)
- February 2022 (5)
- March 2022 (9)
- April 2022 (6)
- May 2022 (4)
- June 2022 (3)
- July 2022 (4)
- August 2022 (5)
- September 2022 (3)
- October 2022 (6)
- November 2022 (4)
- December 2022 (5)
- January 2023 (3)
- February 2023 (2)
- March 2023 (2)
